{"id":29557,"date":"2026-07-30T07:45:00","date_gmt":"2026-07-30T12:45:00","guid":{"rendered":"https:\/\/okdiario.com\/metabolic\/en\/?p=29557"},"modified":"2026-07-30T07:58:20","modified_gmt":"2026-07-30T12:58:20","slug":"scientists-say-your-brain-may-hold-an-inflammation-brake-that-could-shield-it-from-alzheimer-but-switching-it-on-is-the-real-trick","status":"publish","type":"post","link":"https:\/\/okdiario.com\/metabolic\/en\/health\/scientists-say-your-brain-may-hold-an-inflammation-brake-that-could-shield-it-from-alzheimer-but-switching-it-on-is-the-real-trick-29557\/","title":{"rendered":"Scientists say your brain may hold an “inflammation brake” that could shield it from Alzheimer, but switching it on is the real trick"},"content":{"rendered":"\n

Could the brain already carry part of the answer to harmful inflammation? Early laboratory work in Austria points to an immune receptor called Toll-like receptor 10<\/a>, or TLR10, that may help tell brain immune cells when to ease off. <\/p>\n\n\n\n

If that braking role is confirmed, it could offer a new starting point for therapies aimed at Alzheimer\u2019s disease and Parkinson\u2019s disease.<\/p>\n\n\n\n

Biotechnologist Esther Hellmann<\/a> is studying the receptor in human microglia at IMC Krems University of Applied Sciences through a cooperative doctoral program<\/a> with the University for Continuing Education Krems, funded by the Austrian Science Fund. <\/p>\n\n\n\n

The work offers a testable lead, but it remains preclinical and has not shown that TLR10 can prevent, slow, or treat either disease in people.<\/p>\n\n\n\n

The brain\u2019s cleanup crew<\/h2>\n\n\n\n

Microglia<\/a> are the brain\u2019s resident immune cells. Think of them as a cleanup and security team that removes damaged material<\/a>, attacks some threats, and trims extra connections between nerve cells as the brain develops and adapts.<\/p>\n\n\n\n

\n
\n
\n

Read More: He’s 74, discovered fingerboarding during lockdown thanks to his son, and now millions watch him: how a pandemic hobby made him a beloved star<\/a><\/h3>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

That useful response can become damaging when it stays switched on. Long-lasting inflammation may disturb healthy tissue and is increasingly linked to neurodegenerative diseases, although inflammation is only one part of the much larger Alzheimer\u2019s puzzle.<\/p>\n\n\n\n

A 2026 study in Nature Aging<\/a> analyzed cerebrospinal fluid, the liquid around the brain and spinal cord, from 834 people across different stages of Alzheimer\u2019s disease. Researchers found 109 altered microglia-related proteins, with immune patterns changing between early disease and dementia.<\/p>\n\n\n\n

A receptor that may apply the brakes<\/h2>\n\n\n\n

Toll-like receptors<\/a> are sensors used by the innate immune system, the body\u2019s fast first line of defense. Most recognize signs of infection or damage and trigger an immune response. TLR10 stands out because its job is still not fully understood.<\/p>\n\n\n\n

\n
\n
\n

Read More: You are probably falling short on fiber, quietly missing better blood sugar, sharper gut health, but four simple swaps could fix that<\/a><\/h3>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

\u201cTLRs mainly serve pattern recognition by identifying danger signals and initiating an immune response, at least from TLR1 through TLR9,\u201d she said. \u201cWith TLR10, the situation is less clear because the pathway may inhibit inflammatory responses, or its regulatory activity may depend heavily on context.\u201d<\/p>\n\n\n\n

An earlier human-cell study<\/a> found that TLR10 could dampen signaling from another immune receptor. That supports the brake idea, but results from different cell types do not automatically prove that the receptor behaves the same way inside the human brain.<\/p>\n\n\n\n

Why mice left a blind spot<\/h2>\n\n\n\n

One reason TLR10 remains mysterious is surprisingly simple. Mice, a standard tool in biomedical research, do not have a functional version of the receptor<\/a>. That makes the usual laboratory shortcut far less useful.<\/p>\n\n\n\n

The researcher instead works with immortalized human microglia. The word \u201cimmortalized\u201d does not mean the cells cannot be damaged. It means they have been altered so they can keep dividing in a dish, giving scientists enough material for repeated tests.<\/p>\n\n\n\n

She compares an unchanged cell line with another line genetically edited so it no longer produces TLR10. In practical terms, this lets the team ask what changes when the suspected brake is removed.<\/p>\n\n\n\n

\"Doctor

Scientists are investigating how the TLR10 immune receptor may help regulate brain inflammation, a process linked to Alzheimer’s and other neurodegenerative diseases.<\/figcaption><\/figure>\n\n\n\n

Reading every protein at once<\/h2>\n\n\n\n

The experiments use proteomics<\/a>, a broad method for measuring proteins throughout a cell. A specialized form of mass spectrometry separates and identifies those proteins, creating something like a detailed inventory of the cell\u2019s working parts.<\/p>\n\n\n\n

That inventory is enormous. Bioinformatics tools then search the data for patterns that may reveal which pathways change when TLR10 disappears, including pathways tied to inflammation, movement, and communication between cells.<\/p>\n\n\n\n

Microscope work has already found major changes in cell migration and the extracellular matrix around microglia without TLR10. The extracellular matrix is the supportive mesh surrounding cells, a little like scaffolding that also carries signals. These findings are clues, not proof of protection against Alzheimer\u2019s disease.<\/p>\n\n\n\n

Why the finding could matter<\/h2>\n\n\n\n

The most interesting possibility is not simply turning inflammation off<\/a>. Microglia still need to clear debris and respond to danger, so silencing them could create new problems. A useful therapy would have to restore balance rather than pull the plug on the brain\u2019s defenses.<\/p>\n\n\n\n

\n
\n
\n

Read More: Bruce Lee said he never feared the man who practiced 10,000 kicks once: the man he did fear says everything about focus<\/a><\/h3>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

\u201cIf the receptor\u2019s anti-inflammatory effect can be confirmed, it could lay the groundwork for new therapeutic approaches in neurodegenerative diseases,\u201d she said. Reaching that point would likely require researchers to reproduce the results, identify what activates TLR10, test more human cell systems, and show that changing the receptor is safe.<\/p>\n\n\n\n

That road is long. Still, targeting the immune system\u2019s own stop signal offers a distinct idea in a field often focused on removing the protein plaques associated with Alzheimer\u2019s<\/a> disease. At the end of the day, the question is whether microglia can be helped to do their job and then stand down.<\/p>\n\n\n\n

The researcher behind the work<\/h2>\n\n\n\n

The scientist, born in Braunau, Austria in 2001, first studied nutritional sciences at the University of Vienna and later earned a master\u2019s degree in medical and pharmaceutical biotechnology. She also teaches yoga, which gives her a practical counterweight to long evenings in the laboratory.<\/p>\n\n\n\n

\u201cResearch can be very frustrating,\u201d she said, adding that yoga helps and at least keeps her back from hurting. <\/p>\n\n\n\n

The original research profile was published by <\/a>Der Standard<\/a> <\/em>on July 6, 2026.<\/p>\n","protected":false},"excerpt":{"rendered":"

Could the brain already carry part of the answer to harmful inflammation? Early laboratory work in Austria points to an … <\/p>\n

Read more<\/a><\/p>\n","protected":false},"author":19,"featured_media":29562,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-29557","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","resize-featured-image"],"_links":{"self":[{"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/posts\/29557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/comments?post=29557"}],"version-history":[{"count":4,"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/posts\/29557\/revisions"}],"predecessor-version":[{"id":29567,"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/posts\/29557\/revisions\/29567"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/media\/29562"}],"wp:attachment":[{"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/media?parent=29557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/categories?post=29557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/okdiario.com\/metabolic\/en\/wp-json\/wp\/v2\/tags?post=29557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}